Emtriva Prices, Coupons, Copay Cards & Patient Assistance
Emtriva (emtricitabine) is a member of the nucleoside reverse transcriptase inhibitors (NRTIs) drug class and is commonly used for HIV Infection, Nonoccupational Exposure, and Occupational Exposure.
A generic version of Emtriva is available. See emtricitabine prices.
Emtriva prices
Oral Capsule
200 mg Emtriva oral capsule from $531.97 for 30 capsules
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $17.73 | $531.97 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Oral Solution
10 mg/mL Emtriva oral solution from $131.66 for 170 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 170 milliliters | $0.77 | $131.66 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Emtriva Coupons, Copay Cards and Rebates
Emtriva offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Emtriva Advancing Access Co-pay Program
Eligible commercially insured patients may save up to $300 per month with a maximum savings of $3600 per year; for additional information contact the program at 800-226-2056.
- Applies to:
- Emtriva
- Number of uses:
- per prescription per year
Form more information phone: 800-226-2056 or Visit website
Emtriva Advancing Access Co-pay Program Direct Member Reimbursement
Eligible commercially insured patients may be eligible for reimbursement if they were enrolled in the Co-pay Program but paid in full out of pocket for their medication.
- Applies to:
- Emtriva
- Number of uses:
- One rebate per prescription fill
Form more information phone: 800-226-2056 or Visit website
Patient Assistance & Copay Programs for Emtriva
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Emtriva (emtricitabine)
More information please phone: 866-316-7263 Visit website
Provider: Good Days Program
Eligibility requirements:- Must have insurance
- At or below 500% of FPL
- FDA-approved diagnosis
- The patient must also be a US resident with a Social Security Number.
- Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
- Emtriva (emtricitabine)
More information please phone: 877-968-7233 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Emtriva (emtricitabine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español